Laurocapram
CAS No. 59227-89-3
Laurocapram ( Laurocapram; Azone; N-Lauryl caprolactam; Tranzone )
产品货号. M18861 CAS No. 59227-89-3
Laurocapram is a percutaneous enhancer. Upon application to the skin, laurocapram interacts with lipids in the stratum corneum and may enhance the ability of the skin to absorb a hydrophilic chemical.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
200MG | ¥235 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Laurocapram
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Laurocapram is a percutaneous enhancer. Upon application to the skin, laurocapram interacts with lipids in the stratum corneum and may enhance the ability of the skin to absorb a hydrophilic chemical.
-
产品描述Laurocapram, also known as Azone, is a chemical enhancer for skin permeation of drug. Azone markedly fluidized liposomal lipids (as a model lipid system) compared with other enhancers. Azone increased water content in the stratum corneum, as measured by skin conductance.
-
同义词Laurocapram; Azone; N-Lauryl caprolactam; Tranzone
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number59227-89-3
-
分子量281.48
-
分子式C18H35NO
-
纯度98%
-
溶解度——
-
SMILESCCCCCCCCCCCCN1CCCCCC1=O
-
化学全称2H-Azepin-2-one, 1-dodecylhexahydro-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
β-CGRP, human
β-CGRP, human ,a 37-amino acid peptide,is the beta form of Calcitonin-gene-related peptide (β-CGRP), involved extensively in regulation of the cardiovascular and nervous systems. β-CGRP contains a disulphide bridge at the N-terminus, a C-terminal phenylalanine amide important for immune recognition, and an a-helix between residues 8 and 18.
-
Spinacetin
Spinacetin has anti-inflammatory effects, it weakly inhibited nitric oxide production and reduced prostaglandin E2 levels to different extents.
-
JI130
JI130 is able to impair the ability of Hes1 to repress transcription. JI130 treatment significantly reduced tumor volume in a murine pancreatic tumor xenograft model.